Jpmorgan Chase & CO Biolife Solutions Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLFS
# of Institutions
180Shares Held
46.2MCall Options Held
11.6KPut Options Held
800-
Casdin Capital, LLC New York, NY8.71MShares$223 Million16.09% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$140 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$84.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$71.2 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$40.4 Million0.17% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.09B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...